Close

Immunogen (IMGN) Posts Q4 Loss of 71c/Share

July 31, 2015 6:32 AM EDT

Immunogen (NASDAQ: IMGN) reported Q4 EPS of ($0.71), $0.36 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $12.61 million versus the consensus estimate of $15.42 million.

For earnings history and earnings-related data on Immunogen (IMGN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings